<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE COMPANY'S CONSOLIDATED CONDENSED FINANCIAL STATEMENTS AS OF AND FOR THE THREE-MONTH PERIOD ENDED MARCH 31, 1997 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO THE COMPANY'S QUARTERLY REPORT ON FORM 10-Q FOR THE THREE-MONTH PERIOD ENDED MARCH 31, 1997. </LEGEND> <CIK> 0000811240 <NAME> BIOLASE TECHNOLOGY, INC. <CURRENCY> U.S. DOLLARS <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> DEC-31-1997 <PERIOD-START> JAN-01-1997 <PERIOD-END> MAR-31-1997 <EXCHANGE-RATE> 1 <CASH> 460,836 <SECURITIES> 3,250,000 <RECEIVABLES> 173,863 <ALLOWANCES> (22,930) <INVENTORY> 518,027 <CURRENT-ASSETS> 4,470,256 <PP&E> 1,290,012 <DEPRECIATION> (1,066,111) <TOTAL-ASSETS> 4,787,806 <CURRENT-LIABILITIES> 842,926 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 13,392 <OTHER-SE> 3,931,488 <TOTAL-LIABILITY-AND-EQUITY> 4,787,806 <SALES> 134,405 <TOTAL-REVENUES> 134,405 <CGS> 112,870 <TOTAL-COSTS> 112,870 <OTHER-EXPENSES> 277,440 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> (767,734) <INCOME-TAX> 0 <INCOME-CONTINUING> (767,734) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (767,734) <EPS-PRIMARY> (0.06) <EPS-DILUTED> (0.06)